#United States #Nashville #CryoPort #MVE #Cryogenic Monitoring

Introduction

In the realm of life sciences, maintaining the integrity of biological materials is paramount. The introduction of innovative technology can significantly improve the safety, monitoring, and management of sensitive commodities. Recently, Cryoport, Inc. (NASDAQ: CYRX), a prominent leader in temperature-controlled supply chain solutions, announced a significant advancement through its subsidiary, MVE Biological Solutions. They unveiled their integrated Condition Monitoring Solutions designed specifically for their MVE SC 4/2 V and 4/3 V series dewars.

Key Features

This new technology is not just an enhancement; it represents a leap into the future of intelligent supply chain management. Central to this system are two main components: the SmartTag™, a real-time monitoring device with LTE connectivity, and the CryoBeacon™, equipped with long-range Bluetooth Low Energy (BLE) 5.0 technology. Both devices aim to safeguard vital life science materials by providing accurate and real-time condition monitoring as well as visibility.

Real-Time Monitoring

The integration of these devices directly into the dewar lids marks a significant shift in how biological materials can be monitored. The CryoBeacon™ can log internal temperatures down to –200°C and track ambient temperature and humidity conditions. Moreover, users can easily retrieve this data via a QR code scan, facilitating simple access to crucial monitoring information whether the materials are in transit or stationary.

On the other hand, the SmartTag™ allows for continuous visibility with a remarkable battery life of up to 120 days, allowing for alerts and updates on the condition of stored or transported materials.

Secure Data Management

All collected data from these devices is integrated and managed within the MVECloud™, a secure, web, and mobile-based platform compliant with FDA regulations such as 21 CFR Part 11 and GAMP 5. This platform provides users with real-time alerts, comprehensive reporting, and assurance of the safety of their crucial commodities.

Mike Duich, the President and CEO of MVE, expressed the importance of this development:
"We've integrated monitoring technology directly into our dewars so customers can manage their critical biological materials with confidence. SmartTag and CryoBeacon not only simplify monitoring and reporting but empower our customers with the visibility and control they've been asking for."

Future Outlook

The announcement comes as part of Cryoport’s strategy to elevate its market-leading position by introducing subscription-based monitoring services. This initiative aligns perfectly with the growing demand for connected solutions in the life sciences, ensuring not only compliance but also peace of mind for researchers and biopharmaceutical companies.

Cryoport’s Chairman and CEO, Jerrell Shelton, also commented on the launch. He noted, “The introduction of SmartTag and CryoBeacon, powered by Tec4Med, allows MVE to enhance its service offerings while simultaneously generating ongoing revenue streams. This innovative step allows our customers to better manage their sensitive biological materials.”

Conclusion

The launch of MVE Biological Solutions' integrated condition monitoring technologies marks a pivotal moment in the life sciences supply chain field. This new solution is designed to provide comprehensive monitoring, ensuring that all biological materials remain safe, controlled, and effective within the temperature-sensitive framework required for their storage and transport. As we look toward a future replete with innovation, these developments signal an era of enhanced precision and reliability in the management of vital life science materials.

About Cryoport, Inc.

Cryoport, Inc. stands as a reliable partner for biopharmaceutical companies and researchers alike, with a vast offering of temperature-controlled supply chain solutions. With operations extending across the Americas, EMEA, and APAC, Cryoport is well-equipped to address the challenges faced by the life sciences sector as it continues to advance in technology and service offerings. For more details about their services, visit Cryoport's website.